Pancreatic Cancer Research

ResearcherVrije Universiteit AmsterdamActive in the last 2 years

Dongmei Deng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3706-1678; OpenAlex author ID A5067943688. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Fluid shear stress enhances pancreatic cancer motility through YAP activation. Co-author DOI 10.1186/s13148-026-02163-4↗
  2. Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer. Last author DOI 10.3390/biom15071018↗
  3. Metabolites derived from gut microbiota mitigate chemoresistance in pancreatic cancer. First author DOI 10.1080/17474124.2024.2412045↗
  4. The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing. Co-author DOI 10.1097/js9.0000000000001762↗
  5. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Last author DOI 10.1016/j.drup.2022.100864↗
  6. Antibiotics and Adverse Events in Patients with Pancreatic Cancer Treated with Gemcitabine: Looking for Novel Clinical and Preclinical Insights. Co-author DOI 10.1002/onco.13606↗
  7. Of fungi and men: role of fungi in pancreatic cancer carcinogenesis. Last author DOI 10.21037/atm-20-2723↗
  8. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves? Co-author DOI 10.1016/j.critrevonc.2019.102824↗
  9. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of g… Co-author DOI 10.1080/14737159.2018.1544495↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elisa Giovannetti · 9 shared papers, 2018–2026 · strength 1.67
  2. Adam Enver Frampton · 3 shared papers, 2024–2026 · strength 0.78
  3. Juan Deng · 2 shared papers, 2024–2026 · strength 0.61
  4. Giulia Lencioni · 2 shared papers, 2025–2026 · strength 0.61
  5. Geng Xu · 2 shared papers, 2022–2025 · strength 0.41
  6. Geert Kazemier M · 3 shared papers, 2018–2021 · strength 0.35
  7. Alessandro Gregori · 2 shared papers, 2021–2022 · strength 0.32
  8. Mjriam Capula · 2 shared papers, 2020–2022 · strength 0.29
  9. Luca Morelli · 1 shared paper, 2025 · strength 0.26
  10. Laura L. Meijer · 2 shared papers, 2018–2019 · strength 0.19
  11. James Michael Halle-Smith · 1 shared paper, 2024 · strength 0.17
  12. Nabeel Merali · 1 shared paper, 2024 · strength 0.17
  13. Nicola E. Annels · 1 shared paper, 2024 · strength 0.17
  14. Tarak Agrebi Moumni Chouari · 1 shared paper, 2024 · strength 0.17
  15. Keith John Roberts · 1 shared paper, 2024 · strength 0.17
  16. Shivan Sivakumar · 1 shared paper, 2024 · strength 0.17
  17. Eirini G. Velliou · 1 shared paper, 2024 · strength 0.17
  18. Btissame El Hassouni · 1 shared paper, 2021 · strength 0.16
  19. Jisce R. Puik · 1 shared paper, 2021 · strength 0.16
  20. Macarena Perán · 1 shared paper, 2022 · strength 0.16
  21. Heling Wang · 1 shared paper, 2020 · strength 0.13
  22. Eline S. Zwart · 1 shared paper, 2019 · strength 0.10
  23. Arthur T.F. Choy · 1 shared paper, 2018 · strength 0.09
  24. Ilaria Carnevale · 1 shared paper, 2018 · strength 0.09
  25. Stefano Coppola · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.